Tissue expression
Cell line expression
Protein structure

CTIF

Cap binding complex dependent translation initiation factor
KIAA0427 
CTIF is a component of the CBP80 (NCBP1; MIM 600469)/CBP20 (NCBP2; MIM 605133) translation initiation complex that binds cotranscriptionally to the cap end of nascent mRNA. The CBP80/CBP20 complex is involved in a simultaneous editing and translation step that recognizes premature termination codons (PTCs) in mRNAs and directs PTC-containing mRNAs toward nonsense-mediated decay (NMD). On mRNAs without PTCs, the CBP80/CBP20 complex is replaced with cytoplasmic mRNA cap-binding proteins, including EIF4G (MIM 600495), and steady-state translation of the mRNAs resumes in the cytoplasm (Kim et al., 2009 [PubMed 19648179]). [supplied by OMIM, Dec 2009]
More gene data

All Antibodies

 

Filters

Application

Validation method

Reference

Provider

Host

Reactivity

Antibody type

Conjugate

Antigen sequence

Epitope

Antibody

  or   Clear
Enhanced validation
Supportive data in Antibodypedia
Data presented on provider website
Data in Antibodypedia (inconclusive)
Recommended by provider
51 antibodies from 13 providers.

Antibody properties

Applications

or Cancel
AntibodyRefsTypeWBELICCIPIHCFC
Atlas Antibodies
2 antibodies
Invitrogen Antibodies
2 antibodies
antibodies-online
20 antibodies
Novus Biologicals
4 antibodies
Aviva Systems Biology
2 antibodies
GeneTex
2 antibodies
OriGene
2 antibodies
Abnova Corporation
2 antibodies
LSBio
8 antibodies
ProSci
1 antibody
MilliporeSigma / Merck KGaA
3 antibodies
United States Biological
1 antibody
Creative Diagnostics
2 antibodies